/Normalized%20for%20WHT%20BKGNDS/AZ-dental_norm_on_wht.svg)
Arizona Dental Association Endorses iCoreRx
iCoreRx and the Arizona Controlled Substances Prescription Monitoring Program (CSPMP)
Arizona Revised Statutes 36-2606 requires that, before prescribing an opioid analgesic or benzodiazepine controlled substance listed in Schedule II, III, or IV to a patient, prescribers must check the CSPMP. This applies to prescriptions for the preceding twelve months at the beginning of each new course of treatment and at least quarterly while that prescription remains a part of the treatment.
iCoreRx offers an option to integrate with the CSPMP. Streamline the process and improve prescription speed and efficiency while ensuring adherence to Arizona law and boosting patient safety. The integration allows prescribers to directly access the patient's PMP report without the extra step of logging into the Arizona CSPMP site.
Arizona prescribers are required to electronically transmit prescriptions for Schedule II controlled substances that contain opioids. The law went into effect July 9, 2021 after the mandate was temporarily waived in March of 2020 due to COVID. Prescribers are also required to check the Arizona Controlled Substances Prescription Monitoring Program (CSPMP) prior to writing specific prescriptions for controlled substances.
Stay on top of these legal requirements with iCoreConnect’s iCoreRx. Improve your clinical workflow when you ePrescribe all medications, including controlled substances. In addition to meeting those legal requirements, iCoreRx allows you to:
- ePrescribe all medications, including controlled substances, from any device, anywhere
- Connect directly to the Arizona Controlled Substances Prescription Monitoring Program (CSPMP) for immediate access to patient reports
- See interactions and contraindications to improve prescription safety
- Autofill important patient information and favorite pharmacies and prescription combinations to improve speed and increase efficiency
Texas Prescription Monitoring Program (PMP) and iCoreRx
In 2020, Texas law required that pharmacists and prescribers check a patient’s PMP history through Texas PMP AWARxE before dispensing or prescribing controlled substances including: opioids, benzodiazepines, barbiturates, or carisoprodol.
iCoreRx offers an option to integrate with Texas PMP AWARxE. Streamline the process and improve prescription speed and efficiency while ensuring adherence to Texas law and boosting patient safety. The integration allows prescribers to directly access the patient's PMP report without logging into the Texas PMP site.
